Investigating the Impact of TPST-1120 PPAR ¿ Inhibition on Anti-PD-1 Antibody Immunotherapy Efficacy in Pre-Clinical Melanoma Models
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Tempest Therapeutics
Start Date
June 28, 2018
End Date
December 24, 2021
Administered By
Medicine, Medical Oncology
Awarded By
Tempest Therapeutics
Start Date
June 28, 2018
End Date
December 24, 2021